Yi Cheng

mRNA lipid nanoparticle vaccines: current status, challenges and future prospects

Abstract mRNA vaccines have become a clinically validated vaccine platform, as demonstrated by the success of COVID-19 vaccines such as Comirnaty and Spikevax, owing to their rapid design, manufacturing scalability, and capacity to induce in situ antigen expression. A key factor...